Recall Register

Drug recall: Oxycodone Hydrochloride Oral Solution, USP (C-II), 5 mg/5 mL, Delivers 5 mL per Cup, 1 Tray of 10 Cups, Rx Only, For…

Class II FDA enforcement event 89670. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Impurity failure at 0-time of the repackaged lot.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

American Health Packaging started this drug recall on 22 Feb 2022. The firm address in the FDA record is in Columbus, OH. FDA put the recall in Class II. FDA event 89670 has 1 product record. The first FDA enforcement report date is 16 Mar 2022. The record gives the status Terminated, with the termination date 16 Jul 2023. 107 of the 325 drug events that started in 2022 have more product records. The median drug event of 2022 has 1 product record. The openFDA file has 325 drug events that started in 2022 and 299 that started in 2021.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide in the USA

Recalling firm

American Health Packaging, Columbus, OH.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 89670: product records
Recall numberProductQuantityClassStatusReport date
D-0652-2022Oxycodone Hydrochloride Oral Solution, USP (C-II), 5 mg/5 mL, Delivers 5 mL per Cup, 1 Tray of 10 Cups, Rx Only, For Institutional Use Only, American Health Packaging, Columbus, OH 43217. UPC (01) 003 60687 406 40 4; Case NDC#: 60687-406-77, Unit Dose NDC#: 60687-406-4089,880 unit-dose cupsClass IITerminated16 Mar 2022

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Drug events that started in 2022
325
Share of these events in Class II
65%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
43

Other events of the firm

Other FDA enforcement events of American Health Packaging
InitiatedProduct (first record)TypeClassRecords
6 Oct 2026Metoclopramide Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only, Distributed by: American Health Packaging, Columbus, DrugClass II1
19 Aug 2026Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, CDrugClass III1
3 May 2022Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals), 100 mg, 100 Capsules (10 x 10), 10-count blisters per card, 10DrugClass III1
12 Apr 2022Cyanocobalamin Injection, USP, 1000 mcg per mL, For Intramuscular or Subcutaneous Use Only, 25 x 1 mL Vials, Rx only, MaDrugClass III1
20 Dec 2021Metoprolol Succinate Extended-Release Tablets, USP 50 mg, 500-count bottle, Rx Only, Manufactured by: Alkem LaboratoriesDrugClass II1
17 Sep 2021GlipiZIDE Extended-Release Tablets, 2.5 mg, 30 Tablets (3 blister cards each with 10 individually blistered doses), Rx oDrugClass II1
15 Sep 2021Valproic Acid Oral Solution, USP, 500 mg/10 mL, 100 10 mL unit dose cups per case, Rx Only, Packaged and Distributed by:DrugClass II1
12 May 2021Sirolimus Tablets 1 mg, 30 Tablets (5 blister cards x 6 unit doses), Rx only, Packaged and Distributed by: American HealDrugClass III1
7 Jan 2021Nitrofurantoin Capsules USP (Monohydrate/Macrocrystals), 100 mg, 100 per carton (10 capsules x 10 blister cards), Rx onlDrugClass II1
10 Jun 2020Nabumetone Tablets, USP, 500 mg, 100 Tablets per carton (10 tablets x 10 blister cards), Rx only, Distributed by: AmericDrugClass III1

American Health Packaging: all 43 events

Official channels

Cite this page

Recall Register. FDA enforcement event 89670. https://recallregister.com/fda/ii/89670/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide in the USA
What quantity of product is in FDA event 89670?
The FDA record gives this quantity: 89,880 unit-dose cups
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2022 have the same class?
65% of the 325 drug events that started in 2022 are in Class II.